GFM
INSM icon

GF Fund Management’s Insmed INSM Stock Holding History

GF Fund Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Sell
4,563
-43,933
-91% -$5.32M 0.01% 218
2026
Q1 		$7.93M Buy
48,496
+6,269
+15% +$964K 0.13% 105
2025
Q4 		$7.35M Buy
42,227
+37,679
+828% +$6.88M 0.13% 123
2025
Q3 		$655K Sell
4,548
-33
-0.7% -$4.04K 0.01% 214
2025
Q2 		$461K Hold
4,581
– – 0.01% 262
2025
Q1 		$349K Buy
4,581
+825
+22% +$63.1K 0.01% 284
2024
Q4 		$259K Buy
+3,756
New +$271K 0.01% 266

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

GF Fund Management's INSM Position: Q2 2026 in Review

GF Fund Management reduced its Insmed (INSM) stake by 91% in Q2 2026, selling an estimated $5.32M and leaving 4,563 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #218.

GF Fund Management first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.93M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • GF Fund Management held 4,563 shares of Insmed worth $487K as of Q2 2026.
  • GF Fund Management sold 43,933 Insmed shares in Q2 2026, an estimated $5.32M.
  • Insmed made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #218 holding.
  • GF Fund Management first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Insmed position peaked at $7.93M in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.